In May 2018 the World Advanced Therapies & Regenerative Medicine Congress, will bring together 800+ attendees and explore the rapidly developing world of ATMPs (Advanced Therapy Medicinal Products). From clinical translation to commercialisation this congress will bring you the most exciting case studies and new data for stem cells, gene therapy, TCRs and gene editing. Experts in every area will help you tackle the process and regulatory hurdles of developing all new therapeutic formats all the way through manufacture and into the clinic.
The event will take place alongside the co-located World Precision Medicine Congress and Cord Blood World Europe, hosting 200+ speakers, 7 tracks of content across the 3 days, enabling networking opportunities with 800+ leading industry professionals.
Cellular Dynamics Talk – Advanced Therapies and Regenerative Medicine Day 2
Thursday, May 17 | 12:00 pm
Developing cell therapies with iPSC Technologies
Speaker: Wen Bo Wang, Senior Vice President Of Cell Therapy Research And Development, Cellular Dynamics International Inc.
- CDI has four internal cell therapy programs on Ocular, Cardiac, Oncology and Parkinson’s disease. Open to strategic partnerships.
- CDI can offer cGMP iPSC lines from common HLA haplotypes as a platform for cell therapy, with reprogramming license out and contract custom MCB/WCB. Our partners and customers can get a jump start.
- CDI can provide third parties with contract development and manufacturing services (CDMO) to speed development of their cell therapy project by putting together each party’s unparalleled know-how and expertise